Hello Avatar! Welcome back for another week of biotech analysis. For this Sunday’s newsletter we plan to shift the discussion to portfolio analysis. Recently as we read bio-twitter we have noticed a common sentiment from many entrepreneurs who seem to interpret disinterest from investors in an extremely negative way. The reaction is understandable as…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.